reviewTop 1% cited
Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic Review
Epilepsia · 2002 · Vol. 43(2) · pp. 146–153
Jan Claassen✉(Columbia University)Lawrence J. Hirsch(Columbia University)Ronald G. Emerson(Columbia University)Stephan A. Mayer
Abstract
Despite the inherent limitations of a systematic review, our results suggest that treatment with PTB, or any cIV-AED infusion to attain EEG background suppression, may be more effective than other strategies for treating RSE. However, these interventions also were associated with an increased frequency of hypotension, and no effect on mortality was seen. A prospective randomized trial comparing different agents and titration goals for RSE with obligatory continuous EEG monitoring is needed.
Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesNeuroscience and Neuropharmacology ResearchStatus epilepticusMidazolamMedicinePropofolAnesthesiaRefractory (planetary science)PentobarbitalBurst suppressionElectroencephalographyEpilepsy
MeSH terms
AnticonvulsantsHumansMidazolamPentobarbitalStatus EpilepticusPropofolGABA Modulators
Citations
631
FWCI
14.02
field-weighted impact
References
67
Percentile
99%
vs. same field & year
Citations per year
Cited by
Status Epilepticus Severity Score (STESS)
Journal of Neurology · 2008 · 405 citations
References
Persistent Nonconvulsive Status Epilepticus After the Control of Convulsive Status Epilepticus
Epilepsia · 1998 · 635 citations
Determinants of Mortality in Status Epilepticus
Epilepsia · 1994 · 658 citations
APACHE II-A Severity of Disease Classification System
Critical Care Medicine · 1986 · 13,403 citations
Propofol
Drugs · 1995 · 371 citations
APACHE II
Critical Care Medicine · 1985 · 13,529 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
